When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Kidney ischemia - Wikipedia

   en.wikipedia.org/wiki/Kidney_ischemia

   Kidney ischemia [1] is a disease with a high morbidity and mortality rate. [2] Blood vessels shrink and undergo apoptosis which results in poor blood flow in the kidneys. More complications happen when failure of the kidney functions result in toxicity in various parts of the body which may cause septic shock, hypovolemia, and a need for surgery. [3]

3. Rivaroxaban - Wikipedia

   en.wikipedia.org/wiki/Rivaroxaban

   Rivaroxaban, sold under the brand name Xarelto among others, is an anticoagulant medication (blood thinner) used to treat and prevent blood clots. [8] Specifically it is used to treat deep vein thrombosis and pulmonary emboli and prevent blood clots in atrial fibrillation and following hip or knee surgery. [ 8 ]

4. Numerous factors can cause kidney disease. Here are the ... - AOL

   www.aol.com/numerous-factors-cause-kidney...

   AKI - the other main type of kidney disease - can be caused by dehydration, blood loss, urinary tract obstructions such as kidney stones or blood clots, low blood pressure, or heart disease. It ...

5. Nephrotoxicity - Wikipedia

   en.wikipedia.org/wiki/Nephrotoxicity

   Drug-induced glomerular disease is not common but there are a few drugs that have been implicated. Glomerular lesions occur primarily through immune-mediated pathways rather than through direct drug toxicity. Heroin and Pamidronate are known to cause focal segmental glomerulosclerosis; Gold salts therapy can cause membranous nephropathy [4 ...

6. Does Medicare cover Xarelto? - AOL

   www.aol.com/lifestyle/does-medicare-cover...

   Xarelto may help reduce the risk of severe cardiovascular events in conditions such as coronary artery disease and peripheral artery disease. Xarelto oral tablets range in strength from 2.5 mg, 10 ...

7. Direct factor Xa inhibitors - Wikipedia

   en.wikipedia.org/wiki/Direct_factor_Xa_inhibitors

   Factors considered before deciding on whether warfarin or a DOAC or which direct factor Xa inhibitor is used, include: the presence or absence of valvular heart disease, state of kidney function, the risk of stroke and the risk of bleeding. [8]